MaxCyte, Inc.MXCTNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank8
3Y CAGR-26.4%
5Y CAGR-35.6%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-26.4%/yr
vs -30.0%/yr prior
5Y CAGR
-35.6%/yr
Recent acceleration
Acceleration
+3.5pp
Accelerating
Percentile
P8
Near historical low
vs 5Y Ago
0.1x
Contraction
Streak
5 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.99 | -55.8% |
| 2024 | 11.29 | -3.9% |
| 2023 | 11.76 | -6.3% |
| 2022 | 12.55 | -53.9% |
| 2021 | 27.24 | -39.6% |
| 2020 | 45.13 | +1.8% |
| 2019 | 44.34 | -15.1% |
| 2018 | 52.21 | -11.7% |
| 2017 | 59.13 | +27.3% |
| 2016 | 46.44 | - |